APA-referens

Savitz, A. J., Xu, H., Gopal, S., Nuamah, I., Mathews, M., & Soares, B. (2019). Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies. Braz J Psychiatry.

Chicago-stil citat

Savitz, Adam J., Haiyan Xu, Srihari Gopal, Isaac Nuamah, Maju Mathews, och Bernardo Soares. "Efficacy and Safety of Paliperidone Palmitate 3-month Formulation in Latin American Patients With Schizophrenia: A Subgroup Analysis of Data From Two Large Phase 3 Randomized, Double-blind Studies." Braz J Psychiatry 2019.

MLA-referens

Savitz, Adam J., et al. "Efficacy and Safety of Paliperidone Palmitate 3-month Formulation in Latin American Patients With Schizophrenia: A Subgroup Analysis of Data From Two Large Phase 3 Randomized, Double-blind Studies." Braz J Psychiatry 2019.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.